Kezar Life Sciences Stock Shares Owned By Institutions
| KZR Stock | USD 0.77 0.02 2.53% |
Kezar Life Sciences fundamentals help investors to digest information that contributes to Kezar Life's financial success or failures. It also enables traders to predict the movement of Kezar Stock. The fundamental analysis module provides a way to measure Kezar Life's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Kezar Life stock.
Kezar | Shares Owned By Institutions |
Kezar Life Sciences Company Shares Owned By Institutions Analysis
Kezar Life's Shares Owned by Institutions show the percentage of the outstanding shares of stock issued by a company that is currently owned by other institutions such as asset management firms, hedge funds, or investment banks. Many investors like investing in companies with a large percentage of the firm owned by institutions because they believe that larger firms such as banks, pension funds, and mutual funds, will invest when they think that good things are going to happen.
More About Shares Owned By Institutions | All Equity Analysis
Shares Held by Institutions | = | Funds and Banks | + | Firms |
Current Kezar Life Shares Owned By Institutions | 61.57 % |
Most of Kezar Life's fundamental indicators, such as Shares Owned By Institutions, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Kezar Life Sciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Kezar Shares Owned By Institutions Driver Correlations
Understanding the fundamental principles of building solid financial models for Kezar Life is extremely important. It helps to project a fair market value of Kezar Stock properly, considering its historical fundamentals such as Shares Owned By Institutions. Since Kezar Life's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Kezar Life's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Kezar Life's interrelated accounts and indicators.
Click cells to compare fundamentals
Since Institution investors conduct a lot of independent research they tend to be more involved and usually more knowledgeable about entities they invest as compared to amateur investors.
| Competition |
Based on the latest financial disclosure, 61% of Kezar Life Sciences are shares owned by institutions. This is 37.92% higher than that of the Biotechnology sector and 29.61% higher than that of the Health Care industry. The shares owned by institutions for all United States stocks is 57.02% lower than that of the firm.
Kezar Shares Owned By Institutions Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Kezar Life's direct or indirect competition against its Shares Owned By Institutions to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Kezar Life could also be used in its relative valuation, which is a method of valuing Kezar Life by comparing valuation metrics of similar companies.Kezar Life is currently under evaluation in shares owned by institutions category among related companies.
Kezar Life Current Valuation Drivers
We derive many important indicators used in calculating different scores of Kezar Life from analyzing Kezar Life's financial statements. These drivers represent accounts that assess Kezar Life's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Kezar Life's important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 76.5M | 229.7M | 882.1M | 474.3M | 68.7M | 65.3M | |
| Enterprise Value | 67.9M | 213.9M | 833.3M | 455.1M | 52.2M | 49.6M |
Kezar Fundamentals
| Return On Equity | -0.48 | ||||
| Return On Asset | -0.27 | ||||
| Operating Margin | (14.92) % | ||||
| Current Valuation | (105.77 M) | ||||
| Shares Outstanding | 72.8 M | ||||
| Shares Owned By Insiders | 14.83 % | ||||
| Shares Owned By Institutions | 61.57 % | ||||
| Number Of Shares Shorted | 4.15 M | ||||
| Price To Earning | (9.34) X | ||||
| Price To Book | 0.33 X | ||||
| Price To Sales | 8.97 X | ||||
| Revenue | 7 M | ||||
| EBITDA | (104.17 M) | ||||
| Net Income | (101.87 M) | ||||
| Cash And Equivalents | 306.84 M | ||||
| Cash Per Share | 4.49 X | ||||
| Total Debt | 18.93 M | ||||
| Debt To Equity | 0.04 % | ||||
| Current Ratio | 39.64 X | ||||
| Book Value Per Share | 2.32 X | ||||
| Cash Flow From Operations | (81.64 M) | ||||
| Short Ratio | 6.28 X | ||||
| Earnings Per Share | (1.39) X | ||||
| Target Price | 11.67 | ||||
| Number Of Employees | 58 | ||||
| Beta | 0.47 | ||||
| Market Capitalization | 55.74 M | ||||
| Total Asset | 221.24 M | ||||
| Retained Earnings | (350.76 M) | ||||
| Working Capital | 189.21 M | ||||
| Current Asset | 74.47 M | ||||
| Current Liabilities | 2.18 M | ||||
| Net Asset | 221.24 M |
About Kezar Life Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Kezar Life Sciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Kezar Life using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Kezar Life Sciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Kezar Life Piotroski F Score and Kezar Life Altman Z Score analysis. Note that the Kezar Life Sciences information on this page should be used as a complementary analysis to other Kezar Life's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Complementary Tools for Kezar Stock analysis
When running Kezar Life's price analysis, check to measure Kezar Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kezar Life is operating at the current time. Most of Kezar Life's value examination focuses on studying past and present price action to predict the probability of Kezar Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Kezar Life's price. Additionally, you may evaluate how the addition of Kezar Life to your portfolios can decrease your overall portfolio volatility.
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data |
Is Kezar Life's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Kezar Life. If investors know Kezar will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Kezar Life listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.39) | Revenue Per Share 0.096 | Return On Assets (0.27) | Return On Equity (0.48) |
The market value of Kezar Life Sciences is measured differently than its book value, which is the value of Kezar that is recorded on the company's balance sheet. Investors also form their own opinion of Kezar Life's value that differs from its market value or its book value, called intrinsic value, which is Kezar Life's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Kezar Life's market value can be influenced by many factors that don't directly affect Kezar Life's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Kezar Life's value and its price as these two are different measures arrived at by different means. Investors typically determine if Kezar Life is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Kezar Life's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.